6:33 PM
 | 
Nov 30, 2012
 |  BC Extra  |  Company News

BioCryst, Presidio terminate merger

BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) and Presidio Pharmaceuticals Inc. (San Francisco, Calif.) mutually terminated their proposed merger. The boards of both companies approved the termination, which the companies said "was in the best interest of both companies and their respective shareholders at this time." BioCryst said it will host a...

Read the full 231 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >